Thermo Fisher Scientific Inc (TMO)
NYSE: TMOIndustrialsIndustrial Machinery/ComponentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 662.06 0.00%
TMO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $244.79B
- P/E (TTM)
- 35.63
- Forward P/E
- 24.02
- EPS (TTM)
- $18.58
- Dividend yield
- 0.27% ($1.80)
- Ex-dividend date
- Sep 15, 2026
- 52-week range
- 435.27 – 694.33
- Day range
- 651.12 – 671.67
- Volume / Avg
- 1.82M / 2.07M
- Beta
- —
- Shares outstanding
- 369.75M
- Next earnings
- Oct 21, 2026
52-week range
TMO stock today
Thermo Fisher Scientific (TMO) closed at $662.06 on Oct 7, up 0.83% (+$5.48), versus the S&P 500's 0.22% decline. At this level, TMO sits near the top of its 52-week range of $435.27 to $694.33: 4.6% below the high, set on Oct 6, 2026 and 52.1% above the low. TMO is up 14.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 22.5%.
At 35.6x trailing earnings, Thermo Fisher Scientific trades below the peer-group median of 43.9x. Its forward P/E of 24.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 21 before the market opens; analysts expect EPS of $6.40. Thermo Fisher Scientific pays an annual dividend of $1.80 per share, a 0.27% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Thermo Fisher Scientific
Company profileThermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
- Sector
- Industrials
- Industry
- Industrial Machinery/Components
- CEO
- Mr. Marc N. Casper
- Headquarters
- Waltham, MA
- Employees
- 125,000
- Website
- thermofisher.com
Financial highlights
Full financialsIn fiscal 2025, Thermo Fisher Scientific generated $44.56 billion in revenue, up 3.9% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $6.70 billion (+5.8% year over year), for a net margin of 15.0% versus a median of 15.5% in the prior 5 years. Operating margin was 17.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B |
| Growth | +3.91% | +0.05% | -4.58% | +14.55% | +21.71% |
| Net income | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B |
| EPS (diluted) | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 |
Analyst forecast
ForecastConsensus (27 analysts)
strong_buy
Avg. price target
$665.16+0.47%
- Strong buy 4
- Buy 19
- Hold 3
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 21, 2026
- EPS estimate
- $6.40
- Last reported (Q2 2026)
- Jul 31, 2026
- EPS actual vs est.
- $4.68 vs —
Dividends
Dividend history- Annual dividend
- $1.80
- Dividend yield
- 0.27%
- Last payment
- $0.47
- Ex-dividend date
- Sep 15, 2026
TMO news
All TMO news- Is This the Right Time to Add TMO Stock to Your Portfolio?NasdaqTMO, GMED, PAHC, VCYT
- Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher ScientificNasdaqISRG, TMO, GMED
- 3 Medical Instruments Stocks Using GenAI to Navigate Industry WoesNasdaqISRG, TMO, GMED
- Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in FocusNasdaqICE, FAST, DGX, TMO
- Moderna, Illumina lead healthcare gains in September as medtech dragsSeeking AlphaTMO, ILMN, MRNA
- QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared PanelNasdaqQGEN, BDX, TMO, BRKR
- Notable ETF Inflow Detected - XLV, ABBV, TMO, GILDNasdaqXLV, ABBV, TMO, GILD
- Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive TestsNasdaqBDSX, TMO, BIO, VCYT
Thermo Fisher Scientific peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DEDeere & Company | 656.87 | -3.80% | $177.11B | vs TMO |
| ETNEaton Corporation PLC | 431.33 | -3.09% | $167.53B | vs TMO |
| DHRDanaher Corporation | 218.49 | +1.34% | $153.60B | vs TMO |
| VRTVertiv Holdings LLC Class A | 246.49 | -2.63% | $94.90B | vs TMO |
| JCIJohnson Controls International plc | 155.93 | -1.78% | $94.45B | vs TMO |
| BEBloom Energy Corporation Class A | 291.29 | -1.52% | $85.79B | vs TMO |
| ITWIllinois Tool Works Inc. | 261.15 | -2.24% | $74.38B | vs TMO |
| LRCXLam Research Corporation | 329.51 | -1.32% | $412.36B | vs TMO |
Indexes, lists and sector
Index membership
Appears in lists
Thermo Fisher Scientific stock FAQ
What is Thermo Fisher Scientific's stock price today?
TMO last traded at $662.06 as of Oct 7, 4:00 PM EDT, up 0.83% on the day. Prices are delayed at least 15 minutes.
Does Thermo Fisher Scientific pay a dividend?
Yes. Thermo Fisher Scientific pays $1.80 per share annually, a 0.27% yield. The most recent dividend of $0.47 had an ex-dividend date of Sep 15, 2026.
When is Thermo Fisher Scientific's next earnings date?
Thermo Fisher Scientific is expected to report earnings on Wednesday, October 21, 2026. Analysts expect EPS of $6.40.
What is TMO's P/E ratio?
TMO trades at a trailing P/E ratio of 35.63 and a forward P/E of 24.02, compared with a median of 43.9 for its closest peers.
Is Thermo Fisher Scientific in the S&P 500?
Yes. Thermo Fisher Scientific (TMO) is a constituent of the S&P 500 index.
Who is Thermo Fisher Scientific's CEO?
Mr. Marc N. Casper is the chief executive officer of Thermo Fisher Scientific Inc, which has about 125,000 employees.
Has TMO ever split its stock?
Yes. The most recent TMO stock split was a 3-for-2 split on Jun 6, 1996, one of 6 splits on record.